Abstract

Alzheimer’s disease (AD) is the leading cause of dementia and has received considerable research attention, including using neuroimaging biomarkers to classify patients and/or predict disease progression. Generalized linear models, e.g., logistic regression, can be used as classifiers, but since the spatial measurements are correlated and often outnumber subjects, penalized and/or Bayesian models will be identifiable, while classical models often will not. Many useful models, e.g., the elastic net and spike-and-slab lasso, perform automatic variable selection, which removes extraneous predictors and reduces model variance, but neither model exploits spatial information in selecting variables. Spatial information can be incorporated into variable selection by placing intrinsic autoregressive priors on the logit probabilities of inclusion within a spike-and-slab elastic net framework. We demonstrate the ability of this framework to improve classification performance by using cortical thickness and tau-PET images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to classify subjects as cognitively normal or having dementia, and by using a simulation study to examine model performance using finer resolution images.

Highlights

  • Alzheimer’s disease overviewDementia has a long history as a scourge on the quality of life for aging persons, and in recent decades has been a leading cause of death [1, 2]

  • The lasso penalty may have downsides when predictors arise from images, and as we show in prior work, the spike-and-slab lasso can be generalized to a spikeand-slab elastic net prior [24]: pðbjjgj; s0; s1Þ 1⁄4 ENðbjj0; SjÞ

  • Prediction error estimates for both cortical thickness and tau Positron Emisson Tomography (PET) data are displayed in Table 1; model fitness for cortical thickness was explored in other work, but this work did not explore classification performance or utilize tau PET images, and we reproduce model fitness estimates for cortical thickness here for completeness and due to their relevance to the current work [24]

Read more

Summary

Introduction

Dementia has a long history as a scourge on the quality of life for aging persons, and in recent decades has been a leading cause of death [1, 2]. The medical research community has devoted considerable time and effort to understanding dementia’s leading cause, Alzheimer’s disease (AD). The understanding of AD, and dementia in general, has developed significantly in the last century, and is evolving still [1]. Biomarker research has progressed alongside an increased understanding of AD’s etiology. AD pathology is characterized primarily by amyloid plaques and neurofibrillary tangles [2].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call